- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 4, 2026 | 194.88M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 199.2M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 200.3M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 208.7M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 208.9M sh |
| Capex | Q2 2026 · Mar 31, 2026 | $91M |
| Capex | Q2 2026 · Mar 31, 2025 | $87M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $1.09B |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $947M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $11.22B |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $11.39B |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $9.66B |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $12.57B |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $12.5B |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $79.33B |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $75.73B |
| Total Assets | Q2 2026 · Mar 31, 2026 | $91.94B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $88.23B |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $2.72 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $5.51 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $2.36 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $5.22 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $2.76 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $5.61 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $2.41 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $5.34 |
| Net Income | Q2 2026 · Mar 31, 2026 | $544M |
| Net Income | Q2 2026 · Mar 31, 2026 | $1.11B |
| Net Income | Q2 2026 · Mar 31, 2025 | $495M |
| Net Income | Q2 2026 · Mar 31, 2025 | $1.1B |
| Revenue | Q2 2026 · Mar 31, 2026 | $4.26B |
| Revenue | Q2 2026 · Mar 31, 2026 | $8.44B |
| Revenue | Q2 2026 · Mar 31, 2025 | $3.85B |
| Revenue | Q2 2026 · Mar 31, 2025 | $7.88B |